Atlas Trials

Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children

Clinical trial NCT02899702 · WITHDRAWN

Trial details

NCT number
NCT02899702
Sponsor
Hospices Civils de Lyon
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Staphylococcal InfectionStreptococcal Infection
Start date
2020-09-01
Primary completion
2024-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.